Statement of Principles concerning occipital neuralgia (Reasonable Hypothesis) (No. 73 of 2025)

The central concept is that of a “reasonable hypothesis” connecting occipital neuralgia with relevant service. Under the VEA and MRCA, a claim for an injury or disease requires the decision-maker to determine whether the material raises a reasonable hypothesis of connection to service. The SoP lists the minimum factors that must exist for such a hypothesis to be raised. If none of the factors is satisfied, no reasonable hypothesis can exist. The SoP does not say that satisfaction of a factor automatically establishes a reasonable hypothesis; other elements of the claim must also be satisfied, including the link between the factor and service.

The definition of occipital neuralgia is narrow. It requires paroxysmal attacks of severe pain of shooting, stabbing or sharp quality in the posterior scalp, in the distribution of one or more occipital nerves, lasting seconds to minutes. The pain must be associated with dysaesthesia or allodynia on innocuous stimulation of the scalp or hair, and there must be tenderness over affected nerve branches or trigger points. The SoP explicitly excludes five other headache and neuralgia conditions, meaning a misdiagnosis could lead to a claim being assessed under the wrong SoP. The exclusion list is not exhaustive of conditions that may present similarly; it merely clarifies that these common differential diagnoses are not occipital neuralgia for these purposes.

“Clinical onset” and “clinical worsening” are not defined in the SoP but are standard administrative law concepts. Clinical onset means when the condition first became clinically apparent. Clinical worsening means a permanent increase in severity beyond the natural progression of the disease. The factors that refer to “before clinical onset or clinical worsening” require the factor to have occurred or existed before that time point. Some factors require the factor to exist within a specific period (e.g., three months, twelve months) before onset or worsening. Others require the factor to exist “at the time of” clinical onset or worsening, meaning contemporaneous presence.

“Relevant service” is defined in the dictionary to include operational service, peacekeeping service, hazardous service and British nuclear test defence service under the VEA, and warlike service and non-warlike service under the MRCA. This means the SoP does not apply to claims for non-relevant service under the VEA, which have a different standard of proof.

The dictionary also defines “trauma to the neck or back of the head” as traction, stretching, compression or penetrating injury to the neck or back of the head. This is narrower than the ordinary meaning of trauma; it excludes superficial contusions or lacerations that do not involve traction, stretching, compression or penetration. The note gives examples: fracture of occipital bone, cervical spine fracture, subluxation, dislocation, instability, whiplash, strain of cervical ligaments or sprain of cervical muscles. A motor vehicle accident, fall from height, playing sports or gunshot wound are given as circumstances where such trauma may occur, but these examples do not themselves constitute trauma unless the specific injury mechanism is present.

The “inability to obtain appropriate clinical management” factor (factor 11) is a standard provision in SoPs. It applies only to clinical worsening. It catches cases where a person’s occipital neuralgia worsened because they could not obtain appropriate treatment due to their service circumstances (e.g., while deployed). It does not apply to clinical onset. This factor requires careful assessment of what constitutes “appropriate clinical management” and why it could not be obtained.

The primary affected group is veterans, members of Peacekeeping Forces, and members of the Forces under the VEA, and members under the MRCA, who have rendered relevant service and who suffer from occipital neuralgia or die from it. They are the persons who may claim compensation or medical treatment in respect of that condition. The SoP directly affects the evidence they must adduce to support a claim. Without satisfying at least one factor, their claim cannot succeed on the reasonable hypothesis standard.

Legal practitioners and advocates who represent claimants in the veterans’ jurisdiction must be familiar with the SoP. They must identify which factor, if any, is satisfied and gather evidence linking it to service. They must also be alert to the narrow definition of occipital neuralgia, because a claimant diagnosed with a broader condition (e.g., cervicogenic headache) will not meet the definition and cannot rely on this SoP.

Decision-makers in the Department of Veterans’ Affairs (DVA) and the Military Rehabilitation and Compensation Commission (MRCC) apply the SoP when assessing claims. They must determine whether the definition is met and whether any factor is satisfied. This involves interpreting medical evidence against the SoP factors. The SoP reduces their discretion by binding them to a minimum threshold.

Medical practitioners who assess or treat veterans will be asked to provide reports addressing the SoP factors. They need to understand the clinical definition and the requirements for each factor. For example, they must distinguish occipital neuralgia from the excluded conditions, specify the timing of onset or worsening relative to trauma, and comment on whether there is a mass lesion or cervical spondylosis at the relevant levels. Complying with the SoP imposes a documentation burden on clinicians, who may need to review service records to identify relevant exposures.

The Repatriation Medical Authority is the body that makes the SoP. It reviewed sound medical-scientific evidence and concluded that occipital neuralgia can be related to relevant service. The SoP is one of many made under the VEA and MRCA. The Authority is affected in that it must periodically review and update SoPs as medical evidence evolves. This instrument does not amend any previous SoP; it stands alone.

Indirectly, the SoP affects the allocation of public resources. Compensation paid for occipital neuralgia claims will depend on how many claimants satisfy the factors. The narrow definition and specific temporal windows may reduce successful claims compared to a broader approach. This concentrates benefits on those with clear causal links while excluding others whose condition may be less clearly connected. It also creates an incentive for claimants to obtain early and accurate diagnosis and to document trauma and other factors in case of later claim.

The SoP does not impose duties on private individuals. Its legal operation is to bind decision-makers in the administrative system. Under section 120A of the VEA and section 338 of the MRCA, a reasonable hypothesis cannot be found unless the SoP factors are satisfied. This creates a duty on decision-makers to apply the SoP when assessing claims for occipital neuralgia.

Claimants have a right to have their claim determined in accordance with the SoP. They are entitled to present evidence that one or more of the factors exists and is related to their service. The decision-maker must consider that evidence and give reasons if they reject it. Claimants also have a right to seek review of an adverse decision by the Veterans’ Review Board or the Administrative Appeals Tribunal. The SoP will be applied at each level of review.

The SoP creates no private rights of action. It is an administrative instrument, not a statute conferring private law rights. It does not impose duties on employers, medical practitioners or other third parties. However, the factor concerning inability to obtain appropriate clinical management (factor 11) indirectly encourages claimants to seek and document their access to medical care. Failure to obtain appropriate management could, paradoxically, strengthen a claim for worsening if the inability is due to service circumstances. This creates an unusual dynamic where a claimant may benefit from not having received treatment, but only if the inability is service-related and not due to personal choice.

The dictionary defines “relevant service” and “terminal event”. The terminal event definition is relevant for death claims. It lists pneumonia, respiratory failure, cardiac arrest, circulatory failure or cessation of brain function. The SoP does not create a right to compensation in itself; it merely sets the causation standard. The right to compensation arises under the VEA or MRCA.

There is a duty on the Repatriation Medical Authority to base the SoP on sound medical-scientific evidence, as stated in section 7. The Authority is of the view that such evidence exists. This is a statutory obligation. The SoP does not create a duty to review or update it, but the VEA requires review of SoPs within set periods. There is no duty on any person to comply with the SoP outside the claims process. A medical practitioner is not required to use the SoP definition when diagnosing a patient; they may use any clinical criteria. However, if they provide an opinion for a compensation claim, they should address the SoP.

The relationship to service requirement in section 9 means that the factor must itself be related to relevant service. This imposes a duty on the decision-maker to examine the link between the factor and service. For example, if the factor is concussion within three months before onset, the concussion must have occurred during relevant service. The SoP does not say that the claimant must prove the factor was caused by service; it must merely be related to service. That is a lower threshold than causation but still requires a connection.

The SoP itself contains no penalty provisions. It is an evidential instrument, not a criminal or regulatory one. Enforcement occurs through the administrative claims process. If a claimant or their representative provides false or misleading information to support a claim that relies on the SoP, they may be subject to penalties under the Criminal Code Act 1995 (Cth) or the VEA itself. For example, making a false statement in connection with a claim for a pension may be an offence under section 137.1 of the Criminal Code (false information to a Commonwealth entity). The maximum penalty is 12 months imprisonment for a body corporate. The SoP does not mention these penalties but they apply generally.

The VEA also contains provisions for recovery of overpayments and cancellation of pensions where a person obtains a benefit based on false or misleading evidence. Section 205 of the VEA allows the Commonwealth to recover overpaid amounts. The SoP is relevant because if a claim succeeds based on a factor that did not in fact exist, and this is later discovered, the decision may be set aside and any compensation recovered.

The MRCA has analogous provisions. Failure to notify DVA of a material change in circumstances that affects the claim could result in reduction or cessation of payments and potential prosecution.

The SoP itself is enforceable in the sense that decision-makers must comply with it. Failure to apply the SoP could give rise to an error of law that would be reviewable. A decision that does not consider the SoP factors properly may be set aside on review. There is no direct penalty for the decision-maker; the remedy is correction of the decision.

The instrument does not create any offences for medical practitioners who provide reports inconsistent with the SoP. A practitioner may have a different clinical opinion about occipital neuralgia and express it. That would not be a breach of the SoP, but the decision-maker may prefer the SoP definition. If a practitioner deliberately misstates facts to help a claimant, they could face professional disciplinary action or criminal charges.

The “inability to obtain appropriate clinical management” factor (factor 11) must be assessed objectively. The decision-maker must determine whether the inability was due to service circumstances. If a claimant deliberately refused treatment and later alleged inability, the factor would not be satisfied, but there is no penalty for making an unsuccessful claim beyond the cost of time and legal fees.

Overall, the SoP functions as a gatekeeping tool. It reduces the scope for speculative claims by requiring specific causal factors. This reduces the risk of invalid claims consuming public funds. Conversely, it may create incentives for claimants to tailor their evidence to fit a factor, which could raise enforcement issues if fabricated. The system relies on the honesty of claimants and the scrutiny of decision-makers.

The SoP operates under the VEA and MRCA, specifically sections 120A and 338 respectively. It is a legislative instrument made by the Repatriation Medical Authority, not by Parliament. It has the force of law for the purposes of determining whether a reasonable hypothesis exists. It does not override the substantive provisions of the VEA or MRCA; it supplements them by specifying the content of the reasonable hypothesis standard for this condition.

The SoP interacts with other Statements of Principles through section 10. If a factor in this SoP refers to an injury or disease covered by another SoP (e.g., concussion, cervical spondylosis, multiple sclerosis), then the factors in that other SoP apply as in force from time to time. This creates a cascading structure. For example, factor 1 requires concussion or moderate to severe traumatic brain injury. To prove that factor exists, the claimant may need to satisfy the SoP for traumatic brain injury (if one exists). Section 10 ensures consistency: the definition and causation factors for the underlying condition are determined by its own SoP. This prevents the need to duplicate factors in every SoP.

The definition of occipital neuralgia references ICD-10-AM code M54.81, Tenth Edition effective 1 July 2017. While the SoP says the meaning in subsection 6(2) governs, the ICD code provides a reference point for administrative coding. In practice, DVA may use the ICD code for statistical purposes, but the clinical definition in the SoP overrides any classification difference.

The SoP does not interact directly with workers’ compensation or motor vehicle accident schemes in the states and territories, except that a veteran who has received compensation from another source may have their Commonwealth benefits reduced under the VEA or MRCA’s compensation recovery provisions. The SoP is irrelevant to those other schemes, which have their own causation standards.

The dictionary defines “relevant service” by reference to specific categories of service under the VEA and MRCA. This means the SoP does not apply to claims for service that is not relevant service, such as peacetime service under the VEA (which uses the reasonable satisfaction standard rather than reasonable hypothesis). For those claims, the SoP may be used as guidance but is not binding.

The SoP’s definition of occipital neuralgia may conflict with clinical definitions used in other contexts. For example, a diagnosis of occipital neuralgia under standard international headache classification (ICHD-3) might include cases that this SoP excludes. The decision-maker must apply the SoP definition, not the ICHD-3, for the purpose of the claim. This can create tension where a treating doctor uses a broader definition. The practitioner should be aware that the legal definition controls for compensation purposes.

The instrument does not repeal or amend any earlier SoP. It is a new SoP made in 2025. It supersedes any previous SoP concerning occipital neuralgia (if one existed) by operation of section 46 of the Acts Interpretation Act 1901 (Cth) read with subsection 196B(11) of the VEA, which provides that a later SoP revokes the previous one to the extent of inconsistency. The text does not state what it replaces, but the date suggests it is a fresh determination.

The SoP interacts with the Administrative Appeals Tribunal Act 1975 through the review process. The Tribunal must apply the SoP as a binding instrument. It cannot depart from the factors or definition. This restricts the Tribunal’s usual merits review discretion.

The instrument is dated 22 August 2025 and commences on 22 September 2025. It is made under subsection 196B(2) of the VEA. The SoP itself does not contain any indication of prior amendments or predecessor instruments. There is no amendment history on the face of the text.

Legislative instruments registered on the Federal Register of Legislation typically have an amendment history tab, but that is not part of the instrument as provided here. Based solely on the text supplied, there is no record of any earlier versions or amendments. This suggests that this SoP is the current and original determination for occipital neuralgia under the reasonable hypothesis standard as at 2025. However, it is likely that this instrument replaced an earlier SoP: the Repatriation Medical Authority periodically reviews and remakes SoPs based on new evidence. The absence of a revocations clause in the text is unusual; it may be that the earlier SoP is automatically revoked under section 33 of the Legislation Act 2003 because this instrument is a later version dealing with the same subject. But we cannot assume any prior existence from the source.

It is plausible that a previous SoP on occipital neuralgia existed (e.g., No. XX of 2014). If so, this new SoP would supersede it. The notes in the instrument do not mention any transition provisions. Claims lodged before 22 September 2025 would be determined under the previous SoP (if any). Claims lodged on or after that date would fall under this instrument.

The instrument does not contain a review date. Under the VEA, the Repatriation Medical Authority must review SoPs at least every 5 years. This SoP will likely be reviewed around 2030.

For practical purposes, legal practitioners should check the Federal Register of Legislation for any amendment history or related instruments. The source provided does not give a consolidated version showing changes. It is a clean instrument with no amending entries. Therefore, the amendment history cannot be determined from this source alone.

As this is a new instrument effective from September 2025, there are no amendments yet. Future amendments would be published as amending instruments. The SoP may be varied or revoked by a later SoP. The absence of amendment history in the source means the only safe assumption is that this instrument is in its original form.

The instrument itself does not record any litigation history. It is a new SoP that commences on 22 September 2025, so it has not yet been judicially considered. There is no case law from the source specifically applying this instrument.

However, there is abundant case law on the interpretation of Statements of Principles generally, and the “reasonable hypothesis” standard. The High Court in Repatriation Commission v Deledio (1998) established the four-step test for applying SoPs. That test remains binding. The SoP does not override Deledio; it supplies the particular factors for occipital neuralgia. Any litigation on this SoP will involve dispute over whether a factor exists and whether it is related to service.

The Administrative Appeals Tribunal and the Federal Court have often considered the “clinical onset” and “clinical worsening” concepts and the temporal requirements in SoPs. For example, cases have examined what “within the three months before clinical onset” means, particularly when the onset is gradual. These general precedents will apply to this SoP.

The definition of occipital neuralgia may be contested. Claimants may argue that their condition meets the SoP definition even if a doctor used a different diagnostic label. The exclusion of cervicogenic headache, cluster headache, migraine, tension-type headache and trigeminal neuralgia will likely be litigated, particularly where there is overlapping symptomatology. The requirement of a positive response to local anaesthetic block (mentioned in a note) is not a mandatory factor but a diagnostic aid; its absence may be used to argue the condition is not occipital neuralgia.

The factor for cervical spondylosis (factor 4) may raise questions about what constitutes “upper cervical spine” (C1-C3) and whether the spondylosis must be symptomatic. The SoP says “having cervical spondylosis involving the upper cervical spine before clinical onset or clinical worsening.” It does not require symptoms; just the existence of the condition. This may be litigated.

The “inability to obtain appropriate clinical management” factor (factor 11) has been considered in other SoP contexts. The tribunal has held that the inability must be due to service circumstances, not mere personal choice or lack of financial resources. Claimants may argue that remote deployment prevented access to appropriate management.

Given the recency of the instrument, there is no litigation history on this specific SoP. However, the SoP will be subject to challenge as claims are made and reviewed. The first few appeals to the Administrative Appeals Tribunal will likely set interpretive precedents for the factors.

Practitioners should monitor the AAT’s decisions for this SoP number. They may also look to litigation on similar SoPs for other conditions (e.g., trigeminal neuralgia, other headache disorders) for analogies.

In summary, the litigation history is not yet written. The instrument provides fertile ground for disputes over diagnosis, timing, and service connection.

Several traps await the unwary.

First, the definition of occipital neuralgia is narrower than many clinicians might use. It explicitly excludes cervicogenic headache, cluster headache, migraine, tension-type headache and trigeminal neuralgia. A practitioner who diagnoses occipital neuralgia using the International Classification of Headache Disorders criteria may inadvertently include patients who do not meet the SoP definition. For example, cervicogenic headache can present with posterior scalp pain, but it is excluded. The only safe approach is to ensure the diagnostic report addresses each element: paroxysmal attacks of severe shooting/stabbing/sharp pain in posterior scalp lasting seconds to minutes, distribution in occipital nerves, associated dysaesthesia or allodynia, tenderness over nerve branches/trigger points, and positive local anaesthetic block response. If the block is not performed or documented, the claim may be at risk.

Second, the temporal windows are strict. Factors 1 and 2 require the trauma to occur within 3 months before clinical onset or worsening. Factor 3 requires surgery within 12 months. Factor 6 requires herpes zoster within 12 months. These are not flexible. If the trauma occurred 4 months before onset, factor 1 cannot be used. The onset date must be clearly established. For gradual onset, the first appearance of symptoms must be pinpointed. A vague history of “symptoms for years” may make it impossible to meet the 3-month window.

Third, the trauma definition is specific: traction, stretching, compression or penetrating injury. A simple blow to the head without these mechanisms is not sufficient. The note gives examples of circumstances (motor vehicle accident, fall from height, playing sports, gunshot wound) but these are not automatically trauma; they are only examples of where such trauma may occur. The decision-maker must find that the mechanism of injury meets the definition. A concussion alone may not satisfy factor 2 unless it involved traction, stretching, compression or penetration of the neck or back of the head.

Fourth, factor 11 (inability to obtain appropriate clinical management) applies only to clinical worsening, not onset. A claimant whose condition existed before service and worsened due to inability to get treatment may rely on it. But if the condition developed after service, this factor cannot be used for onset. Also, the inability must be due to service circumstances. If a claimant simply chose not to seek treatment, that is not inability. Documented barriers (e.g., no medical officer at a remote posting) are needed.

Fifth, the cervical spondylosis factor (factor 4) requires involvement of the upper cervical spine (C1-C3). Extensive cervical spondylosis at C4-C7 alone does not satisfy this factor. The claimant must have radiological evidence of spondylosis at C1, C2 or C3. Many older veterans have cervical spondylosis but it may be confined to lower levels.

Sixth, the clinical worsening provisions in section 9(2) apply only to cases where occipital neuralgia was suffered or contracted before or during (but did not arise out of) relevant service. This is a complex scope limitation. Legal practitioners must carefully determine whether the condition was pre-existing and whether the service contributed to a worsening, not just a recurrence.

Seventh, the definition of “relevant service” excludes certain types of service. A veteran who rendered only peacetime service under the VEA cannot use this SoP; they would need a different SoP or a different standard of proof.

Eighth, terminal event definition is limited to five causes. Death from occipital neuralgia itself is unlikely; death would be from a terminal event contributed to by the condition. The SoP does not list occipital neuralgia as a direct cause of death. The terminal event must be one of those five. If the death was from a stroke not listed, it may not qualify.

Finally, the instrument does not contain a list of definitions for “concussion” or “moderate to severe traumatic brain injury”. Those terms are not defined in the dictionary. They may be interpreted by reference to other SoPs or clinical guidelines. The lack of definition creates uncertainty and may lead to inconsistent decisions.

For claimants and their representatives, compliance means assembling evidence that satisfies at least one factor and demonstrates its relationship to relevant service. The first step is to obtain a definitive diagnosis of occipital neuralgia that matches the SoP definition exactly. A specialist neurologist or pain physician should provide a report addressing each component of the definition and specifically excluding the five listed conditions. The report should note the result of a local anaesthetic block if performed.

Second, gather evidence of the factor. For trauma factors (1 or 2), obtain medical records showing the trauma and its timing. The records should describe the mechanism of injury (traction, stretching, compression or penetrating injury to neck or back of head) and the date. Service documents (e.g., incident reports, medical evacuation records) should link the trauma to service.

Third, establish the date of clinical onset. If the condition developed after service, obtain a clear history from the claimant and any contemporaneous medical records. If the condition developed during service and later worsened, document the pre-existing condition and the worsening. For clinical worsening factors, the timing is relative to the worsening, not the original onset.

Fourth, for factors like cervical spondylosis (factor 4) or rheumatoid arthritis (factor 9), obtain radiology reports or serology that specifically mention involvement of upper cervical levels (C1-C3). A general diagnosis of cervical spondylosis is insufficient without level specification.

Fifth, for factor 11 (inability to obtain appropriate clinical management), obtain evidence that the claimant sought or needed treatment but could not access it due to service circumstances. Evidence could include witness statements, deployment records showing lack of specialist care, or medical opinion that the treatment was not available. The claimant must also show that this inability caused a material worsening of the condition.

Sixth, ensure the factor is related to service. For example, if the factor is surgery involving the upper neck or base of skull, the surgery must have been performed during relevant service (e.g., for a service-related injury). If the factor is a mass lesion, the mass lesion must be related to service. This may require a separate causal link.

Seventh, for legal practitioners, check if any factor refers to another disease covered by a different SoP (e.g., multiple sclerosis). If so, that SoP must also be addressed. The claimant must satisfy both SoPs: the occipital neuralgia SoP factor and the underlying disease SoP.

Eighth, keep thorough records. The decision-maker will scrutinise the timing windows. A diary of symptoms and treatment history can help establish onset dates. Avoid relying on vague histories.

Ninth, if the claim is for death from occipital neuralgia, the death certificate should list a terminal event from the defined list (pneumonia, respiratory failure, cardiac arrest, circulatory failure, cessation of brain function). The medical evidence must show that occipital neuralgia contributed to that terminal event.

Tenth, be aware that the SoP does not exhaust the possibilities for a reasonable hypothesis. A claimant may argue that a factor not listed is still capable of raising a reasonable hypothesis based on sound medical-scientific evidence not considered by the Authority. However, the legislation gives the SoP binding effect, so such an argument would require challenging the SoP itself, which is difficult. Practical compliance focuses on the factors listed.